San Diego, CA, United States of America

Hongjian Jiang

USPTO Granted Patents = 10 

 

 

Average Co-Inventor Count = 5.6

ph-index = 4

Forward Citations = 43(Granted Patents)


Location History:

  • San Diego, CA (US) (2009 - 2013)
  • Shanghai, CN (2017 - 2022)

Company Filing History:


Years Active: 2009-2022

Loading Chart...
Loading Chart...
Loading Chart...
10 patents (USPTO):

Title: The Innovative Contributions of Hongjian Jiang

Introduction

Hongjian Jiang is a prominent inventor based in San Diego, California. He has made significant contributions to the field of medicine, particularly in the development of treatments for various diseases. With a total of 10 patents to his name, Jiang's work has had a substantial impact on healthcare.

Latest Patents

Among his latest patents, Jiang has developed methods for the use of thyroid beta-agonists, which are useful for treating X-linked adrenoleukodystrophy. Additionally, he has created a thyroid hormone receptor agonist that is effective in treating diseases associated with the thyroid hormone receptor beta. This compound has shown promise in lowering cholesterol while minimizing or eliminating adverse effects on the heart or thyroid hormone axis.

Career Highlights

Throughout his career, Hongjian Jiang has worked with notable companies such as Metabasis Therapeutics, Inc. and Merck Sharp & Dohme Corporation. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research and development in the pharmaceutical industry.

Collaborations

Jiang has collaborated with esteemed colleagues, including Mark D Erion and Serge H Boyer, further enhancing the quality and reach of his innovative work.

Conclusion

Hongjian Jiang's contributions to medical science through his patents and collaborations highlight his role as a leading inventor in the field. His innovative approaches continue to pave the way for advancements in treatment options for various health conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…